Alnylam Pharmaceuticals reported $-240341000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -113.06M 69.96M
Agios Pharmaceuticals AGIO:US $ -94.77M 0.15M
Alnylam Pharmaceuticals ALNY:US $ -240.34M 18.12M
Amgen AMGN:US $ 1476M 423M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Avrobio Inc AVRO:US $ -29833000 1.61M
Biocryst Pharmaceuticals BCRX:US $ -74.2M 56.42M
Biomarin Pharmaceutical BMRN:US $ 120.8M 178.7M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
IONIS PHARMACEUT IONS:US $ -65.17M 289.78M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Moderna Inc MRNA:US 3.66B 1.21B
Neurocrine Biosciences NBIX:US $ 13.9M 21.2M
Novartis NVS:US $ 2222M 14086M
Ptc Therapeutics PTCT:US $ -126.73M 16.54M
Regeneron Pharmaceuticals REGN:US $ 973.5M 1255.5M
Regulus Therapeutics RGLS:US $ -6.72M 0.41M
Sangamo Biosciences SGMO:US $ -43.98M 6.48M
Sarepta Therapeutics SRPT:US $ -105.02M 16.96M
Takeda 4502:JP Y -11358M 69127M
Ultragenyx Pharmaceutical RARE:US $ -152.32M 29.86M
Vertex Pharmaceuticals VRTX:US $ 762.1M 8.01M
Xencor XNCR:US $ 23.59M 49.47M
YTE INCY:US $ 37.99M 525.86M